Stockhouse Podcasts


Podcast #41: Luminor Medical Technologies

February 10, 2017

Luminor Medical Technologies Inc. had a two-part mission. The first challenge was to design a superior means for people with diabetes and pre-diabetes to obtain an accurate diagnosis of their condition. The goal is to save lives, and improve the quality of life for diabetes/pre-diabetes sufferers. According to the World Health Organization:

The starting point for living well with diabetes is an early diagnosis – the longer a person lives with undiagnosed and untreated diabetes, the worse their health outcomes are likely to be.

The numbers here are sobering:

  • 422 million adults live with Type-2 diabetes and more than 1.1 billion have pre-diabetes, 272 million diabetes sufferers are undiagnosed.
  • Blood glucose testing (the standard diabetes test) is available in less than 50% of the developing world
  • In China alone; >600 million people are estimated to currently suffer from diabetes or pre-diabetes, with more than half unaware of their condition

Besides efforts in treating and preventing diabetes, screening for diabetes is paramount. But why is modern medicine performing so poorly in diagnosing diabetes around the World? Researchers submit that some of the reasons are related to the fact that tests are time-consuming, need a complex laboratory setting and validation, or require prolonged fasting.

Luminor’s solution to this health crisis is its Scout DS® Diabetes Screen. While offering equal reliability with conventional testing, the Scout DS is faster, easier to use, and non-invasive (no needles/blood required). In addition, there is no fasting requirement prior to testing.

This leads Luminor’s management team to the second part of their mission: bringing the Scout’s life-saving/life-improving technology to the world, and selling Scout DS® devices to nations around the world which have an urgent need for this technology.


FULL DISCLOSURE: Luminor Medical Technologies Inc. is a paid client of Stockhouse Publishing.